ELND002

· Elan Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELND002, covering 2015-12-14 to 2015-12-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis [Phase 1]